Japanese Red Cross Kyoto Daini Hospital
About Japanese Red Cross Kyoto Daini Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
4
Astex Pharmaceuticals, Inc.
2
Ministry of Health, Labour and Welfare, Japan
2
Associations for Establishment of Evidence in Interventions
1
Bayer
1
Chugai Pharmaceutical
1
Hospira, now a wholly owned subsidiary of Pfizer
1
Joseph Broderick, MD
1
Kyoto Prefectural University of Medicine
1
Kyowa Kirin Co., Ltd.
1
Onconova Therapeutics, Inc.
1
Clinical Trials at Japanese Red Cross Kyoto Daini Hospital
During the past decade, Japanese Red Cross Kyoto Daini Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
2005-06-01
2006-09-01
Completed
8
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
2008-10-01
2016-03-01
Completed
5
Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
2008-10-01
2016-03-01
Completed
6
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
2009-04-01
2013-07-01
Terminated
1,500
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation
2011-07-01
2012-03-01
Completed
162
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daini Hospital" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 4 trials, followed by "Astex Pharmaceuticals, Inc." with 2 trials
sponsored, "Ministry of Health, Labour and Welfare, Japan" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daini Hospital"
#1 collaborator was "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Japanese Red Cross Kyoto Daini Hospital
According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Kyoto Daini Hospital" are
"Acute Myeloid Leukemia" (2 trials), "Colorectal Cancer" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials) and "Sedation" (2 trials). Many other conditions were trialed in "Japanese Red Cross Kyoto Daini Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japanese Red Cross Kyoto Daini Hospital
Most popular intervention types in "Japanese Red Cross Kyoto Daini Hospital" are "Drug" (12 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "UFT adjuvant chemotherapy" (2 trials), "Any approved or standard-of-care therapy" (1 trials), "Blopress (Candesartan)" (1 trials) and "Cypher stent" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japanese Red Cross Kyoto Daini Hospital
The vast majority of trials in "Japanese Red Cross Kyoto Daini Hospital" are
16 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Japanese Red Cross Kyoto Daini Hospital
Currently, there are NaN active trials in "Japanese Red Cross Kyoto Daini Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Japanese Red Cross Kyoto Daini Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Kyoto Daini Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".